Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2025)

Lexaria Bioscience's Short-term Investments history spans 8 years, with the latest figure at $143267.0 for Q4 2025.

  • For Q4 2025, Short-term Investments rose 259.29% year-over-year to $143267.0; the TTM value through Nov 2025 reached $143267.0, up 259.29%, while the annual FY2025 figure was $22093.0, 60.41% down from the prior year.
  • Short-term Investments for Q4 2025 was $143267.0 at Lexaria Bioscience, up from $22093.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $833841.0 in Q3 2021 and bottomed at $22093.0 in Q3 2025.
  • The 5-year median for Short-term Investments is $205485.5 (2023), against an average of $244693.4.
  • The largest annual shift saw Short-term Investments skyrocketed 4215.72% in 2021 before it tumbled 82.82% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $493424.0 in 2021, then crashed by 45.34% to $269707.0 in 2022, then crashed by 73.15% to $72427.0 in 2023, then crashed by 44.94% to $39875.0 in 2024, then soared by 259.29% to $143267.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Short-term Investments are $143267.0 (Q4 2025), $22093.0 (Q3 2025), and $33540.0 (Q2 2025).